Loading...
Header Logo
Keywords
Last Name
Institution

Daniel C Parker

TitleProf,Asst
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentDept of Urology
Phone405/271-6900
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Oklahoma, Norman, OKBSc2007Science
    University of Oklahoma, Oklahoma City, OKMD2011Medicine
    Harvard University, Boston, MAMPHPublic Health
    Temple University Hospital, Philadelphia, PAIntern2012General Surgery
    Temple University Hospital, Philadelphia, PAResident2013General Surgery
    Temple University Hospital, Philadelphia, PAResident2016Urology
    Fox Chase Cancer Center, Philadephia, PAChief Resident2017Urologic Oncology
    University of Oklahoma, Oklahoma City, OKFellow2019Urologic Oncology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. McIntosh AG, Parker DC, Egleston BL, Uzzo RG, Haseebuddin M, Joshi SS, Viterbo R, Greenberg RE, Chen DYT, Smaldone MC, Kutikov A. Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function. BJU Int. 2019 May 30. PMID: 31145523.
      View in: PubMed
    2. Parker DC, Abboud MA, Patel SG. Is Routine Removal of the Ovaries Advisable during Radical Cystectomy? J Urol. 2019 03; 201(3):455-456. PMID: 30266333.
      View in: PubMed
    3. Abboud MA, Topham AK, Parker DC, Burks HR, Cookson MS, Patel SG. Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer. Urology. 2019 Jan; 123:181-185. PMID: 30359713.
      View in: PubMed
    4. Parker DC, Waingankar N. Downstream effects of regionalization: reconciling our predictions with the volume-outcome paradigm. Transl Androl Urol. 2018 Mar; 7(Suppl 1):S72-S76. PMID: 29645017.
      View in: PubMed
    5. Maloney I, Parker DC, Cookson MS, Patel S. Bladder Cancer Recovery Pathways: A Systematic Review. Bladder Cancer. 2017 Oct 27; 3(4):269-281. PMID: 29152551.
      View in: PubMed
    6. Parker DC, Handorf E, Smaldone MC, Uzzo RG, Pitt H, Reese AC. Race and postoperative complications following urologic cancer surgery: An ACS-NSQIP analysis. Urol Oncol. 2017 12; 35(12):670.e1-670.e6. PMID: 28867431.
      View in: PubMed
    7. Cross BW, Parker DC, Cookson MS. Salvage Surgery After Renal Mass Ablation. Urol Clin North Am. 2017 May; 44(2):305-312. PMID: 28411921.
      View in: PubMed
    8. Parker DC, Cross BW. Laparoscopic renal mass cryoablation: an operation in search of an indication. BJU Int. 2017 03; 119(3):363-364. PMID: 28211239.
      View in: PubMed
    9. Parker DC, Kocher N, Mydlo JH, Simhan J. Trends in Urology Residents' Exposure to Operative Urotrauma: A Survey of Residency Program Directors. Urology. 2016 Jan; 87:18-24. PMID: 26494295.
      View in: PubMed
    10. Lee Z, Simhan J, Parker DC, Reilly C, Llukani E, Lee DI, Mydlo JH, Eun DD. Novel use of indocyanine green for intraoperative, real-time localization of ureteral stenosis during robot-assisted ureteroureterostomy. Urology. 2013 Sep; 82(3):729-33. PMID: 23987169.
      View in: PubMed
    11. Mellis AM, Parker DC, Buethe DD, Slobodov G. Primary carcinoid tumor of the ileal efferent limb of an ileovesicostomy: a case report. Case Rep Urol. 2011; 2011:191702. PMID: 22606607.
      View in: PubMed
    Parker's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Same Department Expand Description